BridgeBio Pharma (BBIO) announces FDA clearance of IND application for BBO-8520, a first-in-class direct inhibitor of KRASG12C streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The United States Food and Drug Administration has cleared the investigational new drug application for BBO-8520, a first-in-class orally bioavailable and potentially highly potent small molecule.